Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Shares of Paccar Inc. were surging Friday as investors cheered the 25% tariff President Donald Trump said he would slap on heavy trucks made outside the U.S.

NEW YORK, NY / ACCESS Newswire / September 26, 2025 / The fashion industry has always traded on image. Logos, marketing campaigns, and glossy runway shows built brands into billion-dollar icons.

Wintrust Financial Corporation remains a soft "Buy" as balance sheet and income statement growth continue to impress despite recent outperformance. WTFC's deposits and loans have both grown solidly, with organic deposit growth offsetting increased brokered deposit exposure and commercial loan expansion. Asset quality remains strong, with non-performing assets to total assets at 0.31%, well below the industry average, supporting the bullish thesis.

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

Shares of semiconductor specialist Cirrus Logic NASDAQ: CRUS have delivered a standout performance for investors, climbing over 25% year-to-date and recently carving out a new 52-week high. For a company so closely associated with the success of the world's top smartphones, such a strong market signal often prompts a critical question: Is the stock's best growth now in the rearview mirror?

Investors are showing growing interest in the rapidly expanding Precision Oncology market, which is expected to witness a compound annual growth rate (CAGR) of 8% between 2025 and 2030, according to Grand View Research. Tempus AI TEM and Illumina ILMN are two key players with significant presence in this market.

GE HealthCare strengthens its radiopharmaceutical portfolio by licensing Lantheus' PSMA PET imaging agent, PYLARIFY, for commercialization in Japan.

LIT surges 78.9% from its low to a 52-week high as lithium demand fuel momentum in battery metal miners.

Trump's 100% tariff on imported drugs jolts markets, slamming pharma giants and dragging ETFs like XPH, FTXH, IHE, and PPH lower.

Broadcom Inc. (AVGO) is upgraded to a buy rating due to robust Q3 results and accelerating AI-driven growth. AVGO's revenue growth reaccelerated to 22% YoY, with AI revenue surging 63% and profitability metrics improving significantly. The new partnership with OpenAI further strengthens AVGO's leadership in AI chips and positions ASICs for greater adoption.